Page last updated: 2024-09-03

technetium tc 99m hydroxymethylene diphosphonate and Zollinger-Ellison Syndrome

technetium tc 99m hydroxymethylene diphosphonate has been researched along with Zollinger-Ellison Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cadiot, G; Chosidow, D; Daou, D; Delahaye, N; Faraggi, M; Genin, R; Le Guludec, D; Lebtahi, R; Mignon, M; Peker, MC1

Trials

1 trial(s) available for technetium tc 99m hydroxymethylene diphosphonate and Zollinger-Ellison Syndrome

ArticleYear
Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1999, Volume: 40, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Carcinoid Tumor; Digestive System Neoplasms; Female; Humans; Indium Radioisotopes; Male; Middle Aged; Octreotide; Pentetic Acid; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Technetium Tc 99m Medronate; Zollinger-Ellison Syndrome

1999